Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-20

Clinical Trial Update: Atrioventricular Junction Ablation and Biventricular Pacing for Atrial Fibrillation and Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 trial exploring atrioventricular junction ablation with biventricular pacing for permanent atrial fibrillation and heart failure; current status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella | Conditions: Permanent Atrial Fibrillation | Phase 3 | Status: UNKNOWN